Additionally, Song et al. have developed intracellular-acid-activable dynamic nanoparticles for the tumour-targeted delivery of RSL-3, a ferroptosis inducer acting as a GPX4 inhibitor [185]. The gene discussed is GPX4; the disease is neoplasm.